Industry Insights Logo

Compliance with Inflation Reduction ACT (IRA) and Associated Maximum Fair Price (MFP) Rules for 340B Covered Entities

SPONSORED CONTENT

The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug

Read More »
Industry Insights Logo

Top 10: Visante’s Insights for the Biggest Issues in Health System Pharmacy in 2025

SPONSORED CONTENT

It’s January, which means we’ve released our Top Ten Issues for 2025! The experts at Visante have provided insights into the most pressing issues and transformative opportunities in health system pharmacy for the

Read More »
Industry Insights Logo

Webinar—Resolving 340B Noncompliance: From Reversals to Refunds

SPONSORED CONTENT

Join Apexus at an upcoming webinar, Resolving 340B Noncompliance: From Reversals to Refunds, on Wednesday, January 15. This webinar will review different options available for resolving ineligible 340B purchases, including claim reversals, manufacturer repayments, and other options.

Our expert speakers will

Read More »
Industry Insights Logo

Optimizing Your 340B Program: Ensuring Accurate Capture and Identifying Data Gaps

SPONSORED CONTENT

The 340B Drug Pricing Program offers significant savings to eligible healthcare organizations, enabling them to stretch scarce resources further and provide better services to their communities. However, ensuring your program captures the maximum potential savings and operates optimally requires close monitoring of

Read More »
Industry Insights Logo

Continuous 340B Program Readiness: Your Two-Part To-Do List

SPONSORED CONTENT

You’ve assessed your 340B program, identified compliance concerns, and incorporated necessary corrective actions into your 340B program operations. Now, you can sit back and wait until it’s time for your official HRSA

Read More »
Industry Insights Logo

The Evolving Impact of 340B on Specialty Pharmacy

SPONSORED CONTENT

The 340B program continues to be a central topic of discussion in the pharmaceutical landscape, especially as specialty medications become an increasing portion of healthcare spending. Specialty pharmacies, covered entities (CEs), and manufacturers are navigating a complex environment shaped by regulatory updates, financial

Read More »
Industry Insights Logo

Scoping 340B Referral Capture Opportunity: It’s Bigger Than You Think

SPONSORED CONTENT

Imagine the services you could offer to the community your facility serves if you had additional funding. If you’re a 340B covered entity (CE), referral capture might just pave the way to securing those much-needed funds.

The 340B program provides essential funding

Read More »
Industry Insights Logo

Questions to Ask as you Evaluate Potential Referral Partners

SPONSORED CONTENT

We understand that referrals are often the grayest area of your 340B program. That’s why we’ve been building technology and teams specifically focused on referral capture for more than a decade. As we engage with clients, we pay close attention to what

Read More »
Industry Insights Logo

Maximizing 340B Opportunities Through Effective Pharmacy Reconciliation

SPONSORED CONTENT

Introduction

In today’s evolving healthcare landscape, pharmacy reconciliation has become much more than a routine accounting task—it has evolved into a critical strategic tool. By aligning inventory management, drug procurement, and financial optimization,

Read More »

340B PROVIDER LEADER SPOTLIGHT

Rachael Bowser, Lead Technician, Reedsburg Area Medical Center Community Pharmacy and 2024 Scholarship Recipient for the Apexus Advanced 340B Operations Certificate Program

Rachael Bowser

Q: Where do you live?

Reedsburg, Wisconsin

Q: If a friend came to visit you in your hometown, where would you take them? Where would

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live